Precigen Inc. share price logo

Precigen Inc.

NASDAQ: PGEN

Small Cap

$4.82

+0.09

(+1.90%)

as on

Precigen Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $4.59
    $4.87
    downward going graph

    4.77%

    Downside

    1.04%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.39
    $5.47
    downward going graph

    71.16%

    Downside

    13.38%

    Upside

    downward going graph

Precigen Inc. share price movements today

Previous Close
$4.73
Open
$4.76
Volume
2.9M
Day's Low - High
$4.59 - $4.87
52 Week Low - High
$1.39 - $5.47

Precigen Inc. Historical Returns

1 Month Return
+ 15.87 %
3 Month Return
+ 45.18 %
1 Year Return
+ 223.49 %
3 Year Return
+ 295.08 %
5 Year Return
-24.09 %

Precigen Inc. Stock Fundamentals & Key Indicators

Check Precigen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-0.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-86.3M

Revenue (TTM)

31.6M

Profit Margin

0.00%

Return On Equity TTM

-1145.42%

Precigen Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Precigen Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Precigen Inc. image
Precigen Inc.
BUY$1.7B-24.09%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Precigen Inc. Stock including INR - Dollar returns

The Precigen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Precigen Inc. investment value today

Current value as on today

₹3,52,372

Returns

₹2,52,372

(+252.37%)

Returns from Precigen Inc. Stock

₹2,23,490 (+223.49%)

Dollar Impact

₹28,882 (+28.88%)

Analyst Recommendation on Precigen Inc. Stock

Based on 11 analysts

BUY

81.82%

Buy

9.09%

Hold

9.09%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Precigen Inc.. Average target price of $12.45

Precigen Inc. Share Price Target

Get share price movements and forecasts by analysts on Precigen Inc..

What analysts predicted

61.29%UPSIDE

Target Price

$12.45

Current Price

$4.82

Analyzed by

11 Analysts

Target

$12.45

Precigen Inc. target price $12.45, a slight upside of 61.29% compared to current price of $4.82. According to 11 analysts rating.

Indian Investors' Interest in Precigen Inc. Stock

Search interest for Precigen Inc. Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Precigen Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
1
0
0
1
1
0
2
4
23
Gross Profit
-1
0
0
0
0
0
0
1
2
20
Operating Income
-23
-24
-60
-21
-28
-22
-31
-34
-21
-5
EBITDA
-31
-22
-58
-23
-19
-53
-27
-144
-19
-3
Interest Expense
0
0
0
0
0
0
-
0
2
2
Depreciation
1
1
1
0
0
0
0
0
1
1
Income Before Tax
-33
-23
-60
-23
-19
-54
-26
-146
-23
-7
Income Tax Expense
0
0
-1
0
0
0
0
179
0
-
Net Income
-33
-23
-58
-23
-19
-54
-26
-146
-23
-7
Net Profit Margin
-2691.86%
-2228.92%
-8199.72%
-2516.05%
-1657.73%
-4038.26%
-3112.38%
-5008.35%
-514.85%
-34.10%

Precigen Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
190
230
160
31
31
14
26
6
3
9
Gross Profit
129
168
97
26
-12
-39
20
0
0
3
Operating Income
-125
-137
-505
-86
-86
-91
-75
-99
-135
-106
EBITDA
-168
-97
-349
-68
-67
-77
-62
-89
-123
-243
Interest Expense
0
0
8
18
18
18
6
0
0
3
Depreciation
-
31
33
24
17
13
10
6
4
3
Income Before Tax
-194
-129
-536
-104
-104
-110
-79
-96
-128
-250
Income Tax Expense
-3
-2
-21
0
0
0
0
0
-1
0
Net Income
-186
-117
-509
-170
-170
-92
28
-95
-126
-250
Net Profit Margin
-97.74%
-50.66%
-317.20%
-533.01%
-533.01%
-646.01%
105.23%
-1540.63%
-3216.18%
-2588.21%

Precigen Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-23
-58
-23
-19
-54
-26
-146
-23
-7
Operating Cash Flow
-14
-23
-22
-8
-16
-18
-29
-23
-43
Investing Cash Flow
24
14
5
-65
-6
28
-63
39
20
Financing Cash Flow
-
0
32
78
0
-1
93
0
0
Change in Cash
9
-8
15
4
-23
7
0
15
-22

Precigen Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-126
-514
-170
-170
-92
28
-95
-126
-250
Operating Cash Flow
-104
-124
-77
-77
-55
-65
-66
-68
-87
Investing Cash Flow
104
-151
27
27
-74
226
-3
-20
-1
Financing Cash Flow
4
309
32
32
121
-155
29
110
90
Change in Cash
5
34
-16
-16
-8
5
-40
21
0

Global Institutional Holdings in Precigen Inc.

Funds
Holdings
Patients Capital Management LLC
5%
State Street Corp
3.05%
Vanguard Group Inc
2.94%
SymBiosis Capital Partners, LLC
0.84%
Bank of America Corp
0.41%
See all

Precigen Inc. News & Key Events

  • img

    Today's Timeline - 14 November

    Fri, 10:31 AM

    -

    Precigen receives FDA approval for Papsius, achieving a 51% complete response rate in RRP treatment.

Insights on Precigen Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PGEN stock has moved up by 8.3%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 856.0K → 23.25M (in $), with an average increase of 62.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -146.34M → -7.92M (in $), with an average increase of 359.5% per quarter

About Precigen Inc.

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1/1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV+ solid tumors; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis. Further, it provides UltraPorator, a proprietary electroporation device. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.
OrganisationPrecigen Inc.
Headquarters20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
IndustryBiotechnology
CEODr. Helen Sabzevari MPH, Ph.D.
E-voting on sharesClick here to vote

Key Management of Precigen Inc.

Name

Title

Dr. Helen Sabzevari MPH, Ph.D.

President, CEO & Director

Mr. Rutul R. Shah

Chief Operating Officer

Mr. Donald P. Lehr J.D., Ph.D.

Chief Legal Officer & Corporate Secretary

Dr. Douglas E. Brough Ph.D.

Senior VP & Head of Research

Dr. Amy R. Lankford Ph.D.

Senior VP & Head of Clinical Operations and Regulatory Affairs

Mr. Randal J. Kirk J.D.

Executive Chairman

Mr. Phil Tennant

Chief Commercial Officer

Mr. Steven M. Harasym

VP & Head of Investor Relations

Dr. Bryan T. Butman Ph.D.

Senior VP & Head of CMC

Mr. Harry Thomasian Jr.

Chief Financial Officer

FAQs

What is Precigen Inc. share price today?

Precigen Inc. share price today is $4.82 as on at the close of the market. Precigen Inc. share today touched a day high of $4.87 and a low of $4.59.

What is the 52 week high and 52 week low for Precigen Inc. share?

Precigen Inc. share touched a 52 week high of $5.47 on and a 52 week low of $1.39 on . Precigen Inc. stock price today i.e. is closed at $4.82,which is 11.80% down from its 52 week high and 246.76% up from its 52 week low.

What is Precigen Inc.'s market capitalisation today?

Precigen Inc. market capitalisation is $0.00T as on .

How to invest in Precigen Inc. Stock (PGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Precigen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precigen Inc. Shares that will get you 0.3112 shares as per Precigen Inc. share price of $4.82 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Precigen Inc. Stock (PGEN) from India?

Indian investors can start investing in Precigen Inc. (PGEN) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Precigen Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Precigen Inc. share’s latest price of $4.82 as on June 19, 2026 at 8:45 am IST, you will get 2.0747 shares of Precigen Inc.. Learn more about fractional shares .

What are the returns that Precigen Inc. has given to Indian investors in the last 5 years?

Precigen Inc. stock has given -24.09% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?